Transfusion · 2026
First molecularly characterized Para-Bombay phenotype in Iraq: Clinical, serological and genetic insights with implications for transfusion safety.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Aljebouri Dhargam Muhamed, Aljadiri Mohammed, Alshaikhli Bassam, Alattabi Rawa, Alkhamess Arwa, Aldoori Sajjad, Suleiman Yousif
Аннотация
BACKGROUND: H-deficient states are important in ABO-related transfusion practice. Patients may be misclassified as group O if testing stops at forward ABO typing. Anti-IH may render group O units incompatible and increase hemolysis risk.
STUDY DESIGN AND METHODS: A 70-year-old Iraqi man was referred for failure to obtain compatible blood before knee arthroplasty. ABO testing, crossmatching, antibody screening, anti-H lectin testing, saliva inhibition and molecular analysis of fucosyltransferase 1 (FUT1) and fucosyltransferase 2 (FUT2) were performed.
RESULTS: Forward grouping showed anti-A/anti-B 0 (apparent O), with reverse grouping 4+ with A and B cells. Multiple group O units showed immediate 4+ incompatibilities at room temperature (RT). Antibody screening was pan-reactive at RT, 37°C, and the antihuman globulin phase; the direct antiglobulin test and auto-control were negative. Patient red blood cells were nonreactive with anti-H lectin (Ulex europaeus), while control O cells reacted 4+. Cord O cells were nonreactive. Saliva inhibition demonstrated soluble H and B substances. Exome testing identified a homozygous FUT1 frameshift with wild-type FUT2; the variant is deposited in ClinVar (Variation ID 4526453).
DISCUSSION: Based on Iraqi National Blood Transfusion Center records, this is the first documented molecularly characterized Para-Bombay phenotype in Iraq. Apparent group O with O-unit incompatibility should trigger anti-H lectin testing, secretor evaluation, and molecular confirmation/referral, underscoring the need for rare-donor pathways.
STUDY DESIGN AND METHODS: A 70-year-old Iraqi man was referred for failure to obtain compatible blood before knee arthroplasty. ABO testing, crossmatching, antibody screening, anti-H lectin testing, saliva inhibition and molecular analysis of fucosyltransferase 1 (FUT1) and fucosyltransferase 2 (FUT2) were performed.
RESULTS: Forward grouping showed anti-A/anti-B 0 (apparent O), with reverse grouping 4+ with A and B cells. Multiple group O units showed immediate 4+ incompatibilities at room temperature (RT). Antibody screening was pan-reactive at RT, 37°C, and the antihuman globulin phase; the direct antiglobulin test and auto-control were negative. Patient red blood cells were nonreactive with anti-H lectin (Ulex europaeus), while control O cells reacted 4+. Cord O cells were nonreactive. Saliva inhibition demonstrated soluble H and B substances. Exome testing identified a homozygous FUT1 frameshift with wild-type FUT2; the variant is deposited in ClinVar (Variation ID 4526453).
DISCUSSION: Based on Iraqi National Blood Transfusion Center records, this is the first documented molecularly characterized Para-Bombay phenotype in Iraq. Apparent group O with O-unit incompatibility should trigger anti-H lectin testing, secretor evaluation, and molecular confirmation/referral, underscoring the need for rare-donor pathways.